VISN 6 A1C bridge CPT
Ended Awarded Last action
- Contract number
- 36C24625N0215
- Awardee
-
Tosoh Bioscience, Inc. UEI Q9YNUD9SW2J8
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $35,016
Award facts
- Contract value 98% obligated
- $35,675.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Grove City, OH, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $283 | |
| Supplemental Agreement for work within scope | $659 | |
| Supplemental Agreement for work within scope | -$2,600 | |
| Supplemental Agreement for work within scope | $283 | |
| Supplemental Agreement for work within scope | $18,525 | |
| Original award | $18,525 |
About this award
Tosoh Bioscience, Inc. (doing business as Tosoh USA) received a $35,675.35 firm fixed-price Blanket Purchase Agreement (BPA) call from Veterans Integrated Service Network 6 (VISN 6), a division of the Department of Veterans Affairs, for hemoglobin A1C bridge cost-per-test services. The contract was awarded on November 20, 2024, with an ultimate completion date of March 31, 2025, and will be performed in Grove City, Ohio. This award operates under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule and carries no small business set-aside designation, reflecting the specialized and non-competitive nature of hemoglobin A1C testing solutions. Tosoh Bioscience serves as the prime contractor with no identified subcontractors.
This BPA call is part of a larger $1.71 million indefinite delivery vehicle with VISN 6 that extends through April 20, 2030, enabling the VA network to procure hemoglobin A1C testing instrumentation, reagents, supplies, and cost-per-reportable-result testing services on an as-needed basis to support diabetes diagnosis and management across VA medical facilities in the VISN 6 region. Tosoh Bioscience maintains an extensive portfolio of similar contracts valued at approximately $10.6 million across multiple VA networks, positioning the company as a primary federal supplier of advanced clinical diagnostic laboratory equipment and hemoglobin analyzer solutions to the Department of Veterans Affairs healthcare system.
Quick answers
Who was awarded contract 36C24625N0215?
36C24625N0215 was awarded to Tosoh Bioscience, Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on November 20, 2024.
How much is contract 36C24625N0215 worth?
The government has obligated $35,016 on 36C24625N0215. Its current value, with exercised options, is $35,675.
Is contract 36C24625N0215 an order under another contract?
Yes. 36C24625N0215 is a BPA call under V797D40130-36C24625A0004, a blanket purchase agreement, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract 36C24625N0215 competed?
The extent of competition for 36C24625N0215 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award